Clinical Trial Update: Cardiovascular Safety of Xenon in General Anaesthesia, in Patient With Cardiovascular Risk in Non Cardiac Surgery [Phase 3]

View source ↗

Summary

A Phase 3 trial assessing the cardiovascular safety of Xenon as an anesthetic in high-risk patients undergoing non-cardiac surgery has completed and posted its …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Coronary Artery Disease

Drugs mentioned

• Xenon (xenon)

Snippet

Sponsor: Air Liquide Santé International | Conditions: Elevated Cardiac Risk, Coronary Arteries Disease Risk | Phase 3 | Status: COMPLETED | Results posted: 2014-06-17